Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents
Journal Article
·
· Journal of Medicinal Chemistry
- Brandeis Univ., Waltham, MA (United States). Dept. of Biology
- National Inst. of Allergy and Infectious Diseases, Bethesda, MD (United States). Tuberculosis Research Section
- Univ. of Cape Town, Rondebosch, Cape Town (South Africa). Dept. of Drug Discovery and Development & Inst. of Infectious Disease and Molecular Medicine, H3D Drug Discovery and Development Centre
- Univ. del Piemonte Orientale, Novara (Italy). Dipartimento di Scienze del Farmaco
- Brandeis Univ., Waltham, MA (United States). Dept. of Chemistry
- Univ. of Chicago, IL (United States). Center for Structural Genomics of Infectious Diseases and Dept. of Biochemistry and Molecular Biology
- Univ. of Cape Town (South Africa). MRC/NHLS/UCT Molecular Mycobacteriology Research Unit & DST/NRF Centre of Excellence for Biomedical TB Research, Inst. of Infectious Disease and Molecular Medicine & Dept. of Pathology
- Univ. of Houston, Houston, TX (United States). Dept. of Pharmacological and Pharmaceutical Sciences, College of Pharmacy
New drugs and molecular targets are urgently needed to address the emergence and spread of drug-resistant tuberculosis. Mycobacterium tuberculosis (Mtb) inosine 5'-monophosphate dehydrogenase 2 (MtbIMPDH2) is a promising yet controversial potential target. The inhibition of MtbIMPDH2 blocks the biosynthesis of guanine nucleotides, but high concentrations of guanine can potentially rescue the bacteria. Here in this paper we describe an expansion of the structure activity relationship (SAR) for the benzoxazole series of MtbIMPDH2 inhibitors and demonstrate that minimum inhibitory concentrations (MIC) of <= 1 mu M can be achieved. The antibacterial activity of the most promising compound, 17b (Q151), is derived from the inhibition of MtbIMPDH2 as demonstrated by conditional knockdown and resistant strains. Importantly, guanine does not change the MIC of 17b, alleviating the concern that guanine salvage can protect Mtb in vivo. These findings suggest that MtbIMPDH2 is a vulnerable target for tuberculosis.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- National Institutes of Health (NIH); National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID); National Research Foundation (NRF) South Africa; South African Medical research Council (SAMRC); U. S. Department of Health and Human Services; USDOE
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1466338
- Journal Information:
- Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 11 Vol. 61; ISSN 0022-2623
- Publisher:
- American Chemical Society (ACS)Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections
High Affinity Inha Inhibitors with Activity Against Drug-Resistant Strains of Mycobacterium Tuberculosis
Journal Article
·
Mon Oct 05 20:00:00 EDT 2015
· PLoS ONE
·
OSTI ID:1627766
The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections
Journal Article
·
Wed Sep 29 20:00:00 EDT 2021
· ACS Infectious Diseases
·
OSTI ID:1854352
High Affinity Inha Inhibitors with Activity Against Drug-Resistant Strains of Mycobacterium Tuberculosis
Journal Article
·
Sat Dec 31 23:00:00 EST 2005
· ACS Chem. Biol.
·
OSTI ID:914315